Cannabis Use in Older Adults: A Perspective
Haley V. Solomon, Aaron P. Greenstein, L. DeLisi
Harvard Review of Psychiatry March 3, 2021 DOI: 10.1097/hrp.0000000000000289 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Commentary Peer reviewed |
|---|---|
| Topics | Cannabis |
| Key points | Argues that knowledge about cannabis in older adults remains limited because most evidence comes from adolescent and young adult cohorts and a few small observational studies. Some research on cannabinoids for behavioral and psychological symptoms of dementia shows promising results, but inconsistency across the literature makes conclusions premature; controlled trials in geriatric participants are needed. |
Abstract
Abstract The prevalence of cannabis use among older adults (aged 65 and above) for both recreational and medicinal purposes has significantly increased in recent years. Information regarding the safety of cannabis in this population is important since aging is associated with metabolic changes, multiple morbidities, increases in prescription medication use, and an overall decline in functioning. In this Perspectives article, we review special considerations pertinent to older adults—specifically, the impact of cannabis on cognition and on falls and injuries, its drug interactions, and its potential medicinal applications for treating the behavioral and psychological symptoms of dementia. Knowledge about the role of cannabis in brain health, injury risk, and drug interactions remains limited since the available evidence stems primarily from adolescent and young adult cohorts, plus a limited number of small observational studies with older adults. In terms of utilizing certain cannabinoids to treat the behavioral and psychological symptoms of dementia, some studies have found promising results, but because of the lack of consistency in the literature, it is premature to draw conclusions. Controlled research trials specifically with geriatric participants are needed to understand the effects of cannabis use in this vulnerable population.
Citations in the library
Cited by 2
- Effects of delta-9 tetrahydrocannabinol and cannabidiol on cognitive outcomes following acute use of cannabis for chronic pain. Psychopharmacology September 1, 2026
- Cannabis-Induced Acute Encephalopathy in a 94-Year-Old Woman Due to Family Administration of Cannabidiol (CBD) Products: A Case Report. Cureus April 2023
Cites 7
- The implications of late-life cannabis use on brain health: A mapping review and implications for future research. Ageing Research Reviews February 25, 2020
- Cannabinoids: from pot to lab International Journal of Medical Sciences August 6, 2018
- Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults: A Systematic Review and Meta-analysis JAMA Psychiatry June 1, 2018
- Marijuana Matters: Reviewing the Impact of Marijuana on Cognition, Brain Structure and Function, & Exploring Policy Implications and Barriers to Research International Review of Psychiatry May 4, 2018
- Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review. Biological Psychiatry April 1, 2016
and 2 more in the library